发明名称 Pharmaceutical compositions comprising sorbitan esters
摘要 The present invention relates to a pharmaceutical composition comprising sorbitan esters of carboxylic acids that are useful for the delivery of anti-psychotic drugs.
申请公布号 US9351976(B2) 申请公布日期 2016.05.31
申请号 US201514714621 申请日期 2015.05.18
申请人 ALKERMES PHARMA IRELAND LIMITED 发明人 Perry Jason M.;Deaver Daniel R.;Hickey Magali B.;Remenar Julius F.;Vandiver Jennifer
分类号 A61K31/551;A61K9/00;A61K47/26;A61K31/5513;A61K31/4965;A61K31/497;A61K9/10;A61K31/496 主分类号 A61K31/551
代理机构 Lathrop & Gage LLP 代理人 Lathrop & Gage LLP ;Trinque Brian C.;Heuberger Benjamin D.
主权项 1. A pharmaceutical composition comprising: (a) compound of Formula (III) or (IV):  wherein R3 is—CH2OC(O)R1, —CH2OC(O)OR1, —CH2OC(O)N(R1)2 or —C(O)R1; R4 is—CH2OC(O)R1, —CH2OC(O)OR1, —CH2OC(O)N(R1)2 or —C(O)R1; wherein each R1 is independently selected from the group consisting of hydrogen, substituted or unsubstituted aliphatic, and substituted or unsubstituted aryl; and wherein Y⊖is a pharmaceutically acceptable counterion; (b) sorbitan laurate; (c) polysorbate 20; and (d) an aqueous vehicle wherein the composition forms an aqueous, flocculated, injectable suspension.
地址 Dublin IE